Back to Drug Index
EGYPTIAN PHARMACEUTICAL DIRECTORY

AVASTING 100MG/4ML I.V. VIAL

OFFICIAL RETAIL PRICE EGP 7,056.00
Active Molecule
BEVACIZUMAB
Form & Route
Injection (Vial / Ampoule)
Manufacturer
F.HOFFMAN LA ROCHE > GYPTO PHARMA
Therapeutic Class
ANTINEOPLASTIC
Cost-Saving Equivalent Available: You can save up to EGP 2,116.00 by switching to ABEVMY 100MG/4ML CONC. VIAL FOR I.V. INF. (EGP 4,940.00).
Commercial brands in Egypt sharing the exact same active molecule & dosage form.
Injection (Vial / Ampoule) • MYLAN
EGP 4,940.00 Saves EGP 2,116.00
Injection (Vial / Ampoule) • MYLAN
EGP 17,081.00 +EGP 10,025.00
Injection (Vial / Ampoule) • F.HOFFMAN LA ROCHE
EGP 7,056.00 Same Price
Injection (Vial / Ampoule) • F.HOFFMAN LA ROCHE
EGP 23,529.00 +EGP 16,473.00
Injection (Vial / Ampoule) • F.HOFFMAN LA ROCHE > GYPTO PHARMA
EGP 23,529.00 +EGP 16,473.00
Injection (Vial / Ampoule) • BIOGENERIC PHARMA
EGP 4,940.00 Saves EGP 2,116.00
Injection (Vial / Ampoule) • BIOGENERIC PHARMA
EGP 17,081.00 +EGP 10,025.00
Injection (Vial / Ampoule) • AMGEN > AMGEN SCIENTIFIC OFFICE
EGP 4,940.00 Saves EGP 2,116.00
Injection (Vial / Ampoule) • AMGEN > AMGEN SCIENTIFIC OFFICE
EGP 17,081.00 +EGP 10,025.00
Verified Directory Notice: Official retail pricing and commercial specifications reflect Egyptian MOH/EDA registered records. Always consult a licensed healthcare professional or pharmacist prior to modifying or substituting prescription drug treatments.

System Notice

Confirm Action